We describe the use of low-molecular-weight supramolecular gels as media for the growth of molecular crystals. Growth of a range of crystals of organic compounds, including pharmaceuticals, was achieved in bis(urea) gels. Low-molecular-weight supramolecular gelators allow access to an unlimited range of solvent systems, in contrast to conventional aqueous gels such as gelatin and agarose. A detailed study of carbamazepine crystal growth in four different bis(urea) gelators, including a metallogelator, is reported. The crystallization of a range of other drug substances, namely sparfloxacin, piroxicam, theophylline, caffeine, ibuprofen, acetaminophen (paracetamol), sulindac and indomethacin, was also achieved in supramolecular gel media without co-crystal formation. In many cases, crystals can be conveniently recovered from the gels by using supramolecular anion-triggered gel dissolution; however, crystals of substances that themselves bind to anions are dissolved by them. Overall, supramolecular gel-phase crystallization offers an extremely versatile new tool in pharmaceutical polymorph screening.
We describe the use of low-molecular-weight supramolecular gels as media for the growth of molecular crystals. Growth of a range of crystals of organic compounds, including pharmaceuticals, was achieved in bis(urea) gels. Low-molecular-weight supramolecular gelators allow access to an unlimited range of solvent systems, in contrast to conventional aqueous gels such as gelatin and agarose. A detailed study of carbamazepine crystal growth in four different bis(urea) gelators, including a metallogelator, is reported. The crystallization of a range of other drug substances, namely sparfloxacin, piroxicam, theophylline, caffeine, ibuprofen, acetaminophen (paracetamol), sulindac and indomethacin, was also achieved in supramolecular gel media without co-crystal formation. In many cases, crystals can be conveniently recovered from the gels by using supramolecular anion-triggered gel dissolution; however, crystals of substances that themselves bind to anions are dissolved by them. Overall, supramolecular gel-phase crystallization offers an extremely versatile new tool in pharmaceutical polymorph screening. G el media have been used for over a century for the growth of inorganic, organic and protein crystals [1] [2] [3] [4] [5] . The improved physical characteristics of the resulting crystals (better optical quality, larger size and fewer defects) are usually ascribed to the suppression of convection currents, sedimentation and nucleation afforded by the viscous gel environment 6, 7 . In many instances, the gel is thought to act as an inert matrix within which crystal growth occurs; however, in some cases, the gel structure has been shown to influence the polymorphism, enantiomorphism and habit of crystals 2 . Occasionally, gel fibres may become incorporated into the crystal, giving rise to composite materials 8 . Conventional gels are formed using polymeric or clay-like materials such as gelatine, agarose, polyacrylamide or silica 1, 9 . More recently, a new class of low-molecular-weight gelators (LMWGs) has emerged [10] [11] [12] . The supramolecular nature of such systems gives them a potential inherent advantage in that their formation is readily reversible. This sol-gel transition can be triggered by a range of stimuli, such as changes in temperature, pH, sonication, irradiation or, as in the present work, addition of a chemical trigger in the form of anions [13] [14] [15] . Moreover, the chemically diverse nature of LMWGs means that almost any solvent can be gelled. A diverse range of chemical species form gels, including surfactants, sugars, fatty acids, amino acids, bis(ureas) and others, in a variety of solvents 10, 13 . However, the potential of LMWGs as a medium for crystal growth remains largely unexplored [16] [17] [18] , with the exception of some elegant work on the use of LMWGs for the growth of calcium carbonate 19 and other inorganic minerals 20 , as part of studies on biomineralization.
The reversible nature of supramolecular gels can be used to allow easy recovery of crystals. Conventional hydrogels, in contrast, are limited to water as a solvent, and removal of the gel may involve either acid hydrolysis or heating, both of which may also dissolve the crystals. The diverse array of chemical functionalities that can be introduced in small-molecule gelators allows for tuning of interactions between the gel and growing crystal. LMWGs are generally readily synthesized, so, depending on the system, are relatively inexpensive, particularly if required on a large scale. In this Article we aim to show proof of principle for the growth and recovery of organic crystals from anion-triggered supramolecular gels 21 , and to explore the potential of this medium for influencing crystal growth and form, particularly in active pharmaceutical ingredients (APIs) for which crystal habit and polymorphism is a key economic and formulation problem 22 . Four bis(urea) gelators (1-4) with different spacers and end groups and varying solubility were investigated to demonstrate their potential to act as crystallization media for molecular organic compounds. Compounds 2 and 4 have been reported previously 23, 24 . Novel compounds 1 and 3 were prepared by standard methods as detailed in the Supplementary Information. Gelators 1-3 were chosen because they reliably form gels in a number of solvents ranging from aqueous systems to toluene. The fibrous nature of the gels is evidenced by scanning electron microscopy (SEM) images of the dried xerogels (Fig. 1a,b) . Compound 4 is a metallogelator that forms blue gels with substoichiometric amounts of CuCl 2 in methanol/water mixtures 23 . Between them, these gelators can gel a range of solvents, at different temperatures (T gel ), and with a different critical gelator concentration (CGC). This class of compounds has the potential to form the basis of a library of gelators that will allow the selection of gel properties and specific functionalities to match compound and crystallization conditions of interest. The synthetic versatility of these gelators could also in principle allow the incorporation of tailored heteronucleating functionality. Although we focus upon bis(urea) compounds, the concepts outlined herein equally apply to any LMWG.
Crystallization experiments were undertaken using a range of organic compounds of both drug and non-drug species in parallel in both gel and solution media. We undertook an initial screen using candidate compounds 2-hydroxybenzyl alcohol (HBA, 5), aspirin (ASP, 6), carbamazepine (CBZ, 7), 1-(3-methylsulfanyl-phenyl)-3-pyridin-2-yl-urea (SPU, 8) and 1,3-bis(m-nitrophenyl)urea (NPU, 9). We then carried out a detailed study on CBZ with all gelators, and a follow-up study on gelator 3 with a much wider range of pharmaceutical compounds. For the initial screen, HBA was chosen because it forms a cocrystal 25 as well as a pure phase and hence might exhibit further polymorphism. ASP is an example of a very common drug substance that shows little polymorphism, and its two closely related forms have been the subject of recent controversy 26, 27 . In contrast, CBZ, an anticonvulsant, serves as a model compound for many groups engaged in the study of crystal polymorphism [28] [29] [30] [31] [32] . There are four known polymorphs of CBZ as well as a number of co-crystals. Recently, the fourth form was grown using a polymer heteronucleus 33 . Details of the forms relevant to this paper are shown in Table 1 (ref. 28 ). The two urea derivatives were included because they bear the same functional groups as the gelators themselves, and therefore might potentially interfere with gelation or be templated by the gelators. Both 1,3-bis(m-nitrophenyl)urea (NPU) and 1-(3-methylsulfanylphenyl)-3-pyridin-2-yl-urea (SPU) are also highly polymorphic 34, 35 . Results on CBZ crystallization proved to be the most diverse, so this substrate was studied in detail with all gelators. Experiments on the remaining compounds, together with a larger and more diverse set of pharmaceuticals, focused on 2 and particularly 3.
Gel-drug interactions
In crystallizing drug molecules from supramolecular gels it is important to establish whether the presence of the drug molecule has any effect on the gelation process. This aspect was studied using compound 1 and carbamazepine. Compound 1 is a versatile gelator, forming transparent gels in a variety of apolar solvents, consistent with the lipophilic triethoxysilane moiety. For CBZ crystal growth, toluene and CHCl 3 /toluene solvent mixtures dissolve both gelator and crystallization substrate in the sol state and form a gel upon cooling. The typical solid-like rheological properties of the pure gels were confirmed by stress-sweep rheometry, where the storage modulus (G ′ ) proved to be 1.5 orders of magnitude larger than the loss modulus (G ′′ ), consistent with solid-like behaviour (Fig. 2a) . The relatively large value of G ′ confirms that 1 forms strong gels 10 . The rheological properties of 1 were also examined in the presence of CBZ to confirm and quantify the gelation in the presence of the crystallization substrate. CBZ had essentially no effect on the magnitude of the storage and loss moduli of the gel. Interestingly, however, the presence of CBZ (1% by weight) resulted in a marked increase by approximately one order of magnitude in the yield stress.
This effect is in direct contrast to anion binding by bis(urea) gels, in which the competition between anion binding and gelator selfassociation results in marked anion-dependent decreases in gel strength and yield stress 24 . The CBZ does, however, lower the gelsol transition temperature (T gel ; Supplementary Fig. S1 ). Nuclear magnetic resonance (NMR) titration experiments showed only very weak apparent binding of CBZ to 1 with log K 11 ¼ 0.84 (8) in CDCl 3 and a similar (albeit less precise) value in toluene at 70 8C above the T gel . Variable-temperature (VT) NMR spectroscopic experiments show that the gelator has a marked effect on the chemical shift of CBZ, which is probably linked to the disruption of CBZ dimer formation 28 in solution (see Supplementary Information). Because of its gelation ability, the host itself is also likely to undergo significant self-association and hence the competition between both gelator and CBZ aggregation and gelator-CBZ binding results in a low overall apparent binding constant. We therefore conclude that the increased yield stress may not be a result of specific binding of the CBZ to the gelator, but could arise from the physical support of the gel by solid CBZ crystals. This support can be visualized by examination of Fig. 1c , which shows the xerogel of 1 in which CBZ crystals have grown.
The influence of acetate anions on the gelation of 1 was also probed by stress-sweep rheometry. Acetate was chosen, because it is strongly bound by ureas, and previous work on 2 has shown that acetate induces the most significant reduction in gel strength 24 . Anion addition was carried out on 10-ml samples of 1 in toluene in a concentric cylinder couette with addition of 100 ml of MeCN, in which a varying amount of tetrabutylammonium (TBA) acetate was dissolved. Consistent with previous work, acetate binding brings about a significant weakening of the gel both in terms of G ′ and yield stress (Fig. 2b) . Addition of one molar equivalent of acetate is sufficient to completely dissolve the gel. The acetonitrile was required for solubility reasons, and addition of the same volume of pure acetonitrile without anion does not significantly influence the gel strength. Thus, addition of acetate anions represents a feasible way to conveniently break down the gel matrix and hence retrieve crystalline material formed within the gel.
Crystallization from solutions containing 1 wt% CBZ was realized in toluene gels of different concentrations of 1 (Fig. 3) . The drug and the gelator in each case were warmed in the solvent and the sample allowed to cool, resulting in the formation of a clear, transparent gel over 5 min. Crystals of CBZ typically form 8-12 h after gelation. Control crystallizations of CBZ under identical conditions without gelator were undertaken in parallel. The polymorphic form of the resulting CBZ crystals was analysed by single-crystal and/or X-ray powder diffraction (XRPD; see Supplementary Information). In both gel and reference samples at all concentrations studied, the kinetically stable needle-like form II appeared first. Over a period of 2 days, conversion to the thermodynamically favourable form III was observed in the reference samples. This process is significantly slowed in the gel matrix. The reasons for this retardation are unclear, but may relate to the much more limited convection in the gel samples, slowing down dissolution of the kinetic form (Fig. 3c) . Although no unusual polymorph progression or crystal habit were detected, crystals grown 0.1000 1.000 10.00 100.0 1,000
Osc. stress (Pa) 100,000 100,000 inside the gelator network exhibited a tendency to more welldefined crystal faces and larger sizes, in some cases up to 20-30 times the size of the reference samples (Fig. 3d) .
The formation of form II can be completely avoided in a mixed solvent system of CHCl 3 :toluene (1:9 v/v). CBZ and 1 were dissolved in the chloroform with heating. Following cooling of the solution, the addition of toluene resulted in the immediate formation of a rigid gel. Crystals of CBZ form III were produced 1-2 days after gelation. Crystallization was faster in the non-gel reference sample and occurred after 1-12 h. For all samples, the crystals were smaller than in the comparable pure toluene gels, but again, crystals obtained from the gels tended to grow to larger sizes (Fig. 3) . Crystal growth results on CBZ are summarized in Table 2 .
Recovery of the CBZ crystals grown in the gel phase was readily achieved by anion-switching. Adding excess TBA acetate as a solid on top of the crystal-containing gel leads to rapid dissolution of the gel. From the resulting solution the crystals can be easily recovered by filtration. There was no visible degradation of the crystalline sample observed by optical microscopy or by X-ray crystallography. This facile breakdown of the surrounding gel network is a distinct advantage of LMWGs in comparison to polymer gels such as silica.
Crystallization of CBZ from other gels. Analogous CBZ crystallization experiments were undertaken using gelators 2 and 3, which are particularly versatile in their ability to gel a wide range of solvents. The results are summarized in Table 2 , and selected photographs are given in the Supplementary Information (Fig. S3) . Gel characterization data for 2 have been reported previously 24 . SEM data of a xerogel of 3 are shown in Fig. 1b , and rheometry and additional SEM data are given in the Supplementary Information (Figs S4,S5) . In contrast to 1, gel formation by 2 in toluene solutions containing chloroform was found to be retarded by the presence of CBZ. Other solvents gelled successfully, although at high concentrations of CBZ in 1:9 CHCl 3 :toluene, samples of 3 formed only partial gels. TBA acetate was found to break down gels of both 2 and 3 in all cases except for the pure toluene gels, where the acetate salt is insufficiently soluble, or the aqueous gels, where the anion binding is apparently too weak to destroy the gel. Figure 4 shows an example of the use of acetate to recover a single crystal of CBZ form III grown in a 1:9 CHCl 3 :toluene gel of 3.
As observed with 1, the toluene gels of 2 and 3 resulted in a mixture of needles of form II and blocks of form III. By adjusting the concentration of CBZ it proved possible to grow either form; higher concentrations of CBZ result in form II needles and lower concentrations give form III blocks. Varying the ratio of cosolvent to toluene had a similar effect, with more CHCl 3 or acetonitrile requiring higher concentrations of CBZ to induce crystal growth and growth of form II. In 1:9 v/v acetonitrile:toluene mixtures, only form III blocks were observed, with slightly higher concentrations of CBZ required to induce crystal growth in the gel samples of 3 (.20 mg ml 21 ) compared with solution (.15 mg ml 21 ). Some of the crystals showed different morphology to the normal equant shape and were elongated block-shaped 2, 36 . These crystals proved to be twinned, explaining their different morphology 37, 38 . In ethyl acetate solutions in the absence of gel, form II grew rapidly before gradually converting to form III over several days. In gels of 3, form II was also produced, with nucleation appearing to occur on the glass and crystals growing into the gel. No evidence of conversion to form III was observed, even after several months. In contrast, crystallization from ethyl acetate gels of 2 resulted in the isolation of CBZ as the thermodynamic form III, even at high concentrations of CBZ (50 mg ml 21 ). Other forms of carbamazepine were also encountered. Acetone gels of 2 containing 50 mg of CBZ after 2 weeks formed a large single crystal characterized as the triclinic acetone solvate 39, 40 . Parallel experiments in pure acetone did not produce any crystals. In this case, the gel induces crystallization at lower saturation than the level required for a pure solvent crystallization.
Crystallization of CBZ in MeOH:H 2 O (8:2) gels of 2 at 0.1% by weight containing 50 mg of CBZ and parallel reference crystallization without gelator at the same concentration of CBZ both proved to be the monohydrate form of CBZ and were similar in size and shape to that from the pure solvent crystallization 31, 32 . In DMSO:water solution in the absence of gel, CBZ formed long, needle-like crystals (at concentrations in excess of .30 g ml 21 ) that were shown to be pure carbamazepine dihydrate by XRPD 28 . At low CBZ concentrations, no crystal growth was observed in the gels of 2 and 3. However, at higher concentrations, clumps of very fine crystals formed inside the gel of 3, exhibiting a powder diffraction pattern corresponding to the relatively unusual CBZ form I (Supplementary Fig. S6 ). Form I is the high-temperature form of CBZ and is normally produced from the melt at 170 8C. It has also been shown that dehydration of the dihydrate can lead to form I under conditions of low humidity 41 . The formation of form I in the gel under the same conditions that give the dihydrate from solution is a surprising result and suggests that the LMWGs can have a significant effect on crystal form. IR spectroscopic experiments carried out on the wet samples confirmed that a pure form I rather than the dihydrate is formed in the gel phase.
Crystallization of other substrates
In addition to the detailed work on the highly polymorphic CBZ, we also undertook a range of crystallization and control experiments on Supplementary Fig. S7 ). An equally concentrated solution of ASP in MeCN does not crystallize under the same conditions, suggesting that the gel can be used to induce crystallization. The crystal form proved to be the conventional form I. Crystals of HBA were successfully grown from both toluene gels of 3 and toluene solution and proved to be the known polymorph 42 . The crystals obtained from the gel were significantly larger, however, with better developed and more regular faces (Supplementary Fig. S8 ).
The urea derivative SPU crystallized or precipitated from a wide range of gels of gelators 1-3 in a range of solvents: toluene, ethyl acetate, DMSO and methanol. Solution-phase methods give a variety of polymorphs I-IV depending on conditions 35 , whereas gels generally give the most thermodynamically stable form IV.
The other urea derivative, NPU, has three concomitant polymorphs, designated as a, b and d. Growth on siloxane selfassembled monolayers (SAMs) also recently revealed a fourth polymorph, and a hydrate form is known 43 . There are few reliable means to crystallize these forms free of one another with the exception of growth on Au-thiol SAMs 44 , although slurry methods and fast cooling from a supersaturated acetic acid solution were found to be effective at producing the pure b form 34 . Crystallization of NPU from gels of 2 in MeCN, ethyl acetate, CHCl 3 and MeOH:H 2 O was successful, but resulted in no control over the crystal form. In general, the yellow prism a form was found at the air/gel interface, and the white needle b form within the gel matrix in the CHCl 3 , ethyl acetate and MeCN gels. Interestingly, for the case of ethyl acetate, gel-phase crystallization gave a distinctive needle-shaped morphology, whereas from solution, plateshaped crystals are obtained. The MeOH:H 2 O gels gave the hydrate form at most concentrations, although the needle-morphology b form was also observed in more concentrated samples.
Attempts to recover NPU crystals by adding acetate anion as the TBA salt to the gels resulted in the dissolution of both the gel and also the crystals in the cases of gels in MeCN, ethyl acetate and CHCl 3 . The gels and crystals of NPU from MeOH:H 2 O are unaffected by the addition of acetate. We suspected that this dissolution results from a specific anion-NPU interaction. Solution-phase 1 H NMR spectroscopic titration confirmed that NPU binds strongly to acetate with a binding constant log b 11 ¼ 3.7(1) in acetonitrile, and the host:anion species is more soluble in the solvents used, therefore leading to the rapid dissolving of any crystalline material.
The anion-recovery method is therefore likely to be limited to compounds that do not themselves compete with the urea gels for anion binding.
Scope for crystallization of drug substances
Compound 3 is a particularly versatile gelator and we decided to focus attention on the breadth of the technique using this compound. Gel-phase and parallel solution-phase crystallizations were carried out for the following pharmaceutical compounds: sparfloxacin, piroxicam, theophylline, caffeine, ibuprofen, acetaminophen (paracetamol), sulindac and indomethacin. Experiments were carried out under empirically determined conditions designed to bring about crystallization in the following solvents: 1:9 CH 3 CN:toluene, 1:9 CHCl 3 :toluene, ethyl acetate, 1:1 DMSO:H 2 O and 3:2 MeOH:H 2 O. All of these solvent mixtures form thermoreversible gels with 3, and the first three break down upon the addition of acetate anion. The substrates were chosen as commonly available drug substances that represent a wide range of structures and functional group types, and are either polymorphic, form hydrates or otherwise exhibit interesting crystal packing. The results of these experiments are listed in Supplementary Table S1 . Of the 40 combinations tested, gel formation was observed in all but seven cases. In 19 cases, gels formed in the presence of drug substances were at least as strong as the native gels and of similar appearance. In 14 cases, the gels appeared weaker, leaked solvent or appeared disrupted by the presence of the drug substance. The high solubility of many of the compounds meant that often the concentration of drug molecules was equivalent to, or greater than, that of the gelator. In eight cases, no crystallization occurred from either the gel or solution phases over a period of 3 weeks. Crystallization was found to occur in solution but not the gel in six instances. In many cases the crystals obtained from both gel and solution were in the same form and of similar appearance, although some different morphologies were noted.
A particularly interesting difference between gel-phase and solution crystallization behaviour occurs in the anti-inflammatory drug piroxicam (Supplementary Fig. S9 ). Piroxicam has three anhydrous forms and a hydrate that are readily distinguished by IR spectroscopy 45 . Crystallization from 1:9 acetonitrile:toluene gels of 3 produced fast-growing, needle-like form II in the gel and large block-shaped crystals of the slow-growing form I. In 1:9 chloroform:toluene gels a clump of form II was obtained from solution and at the gel surface, whereas blocks of form I were obtained from the bulk of the gel. In ethyl acetate the gel was partially disrupted by the growth of several clumps of form II. In DMSO:water, yellow blocks of the hydrate were identified from solution, whereas the kinetic form II was recovered from the gel. In methanol:water, small yellow blocks of the piroxicam hydrate were seen dispersed throughout the gel systems and on the bottom of the corresponding solution. Addition of TBA-acetate led to the dissolution of the crystals as well as the gel, and samples were extracted for analysis manually.
Crystallization in a metallogelator
To demonstrate the versatility of the LMWG approach to crystallization we also studied one substrate (CBZ) with metallogelator 4, which gels in methanol in the presence of copper(II) halides 23 .
Crystal growth of CBZ from copper(II) chloride/4 in 1:1 v/v MeOH:water was studied in parallel with gelator-free reference samples. Under these conditions, 4 forms clear blue gels after the addition of 0.4-0.7 equiv. of CuCl 2 . 2H 2 O with brief sonication 46 . In all cases, gelation was rapid and occurred long before any visible crystallization. Figure 5 shows CBZ crystallization in the metallogel of 4 after 1 week. Remarkably, there is a clear change of crystal habit when compared to the needle-like CBZ hydrate crystals grown in the reference samples. Unit cell determination by single-crystal X-ray diffraction, however, confirmed this material to be the dihydrate form of CBZ. The presence of the labile copper(II) does not result in the isolation of any copper-CBZ coordination complexes, although complexation could be an issue for other drugs that are more able to ligate the metal centre. In the absence of complex formation, however, metallogelators offer an added dimension to the possible options for gel tuning.
Interestingly, the difference in habit between gel and solutiongrown CBZ dihydrate is dependent on the amount of copper salt added in the formation of the metallogel. With 0.3 equiv. of CuCl 2 , gelation is incomplete, but crystals are clearly shorter than the reference samples. With the addition of 0.4 equiv. of the copper chloride, complete gelation is achieved, and only small crystals are observed. At higher concentrations of the metal ion, the formation of long blade-like structures was observed (0.5 equiv.), as well as small daughter platelets growing from a central strut (0.6 equiv.) and tree-like growths (0.7 equiv.). Recently, oriented attachment growth has led to similar appearing metal nanostructures in a surrounding polymer matrix [47] [48] [49] . One possible explanation for the formation of these morphologies is that the amount of copper salt influences the gel strength 23 and hence the rate of convection within the gel. This factor in turn influences the degree of nucleation, with the result that daughter crystals nucleating on a parent CBZ needle become predominant over spontaneous nucleation. SEM micrographs (Fig. 6 ) reveal what we believe is early stages of CBZ growth inside the gel and show crystals encased by the fibrous matrix. Daughter crystals growing on a large central mother crystal are frequently observed, and are similar in appearance to the larger structures observed under the optical microscope. It appears that the gel fibre network 'chokes off' regions on the central crystal, perhaps restricting crystal surface area and leaving only certain regions available for further growth to occur.
Conclusions
We have demonstrated the use of LMWGs as a medium for organic crystal growth. The supramolecular nature of these gels allows for the facile recovery of crystals upon the addition of acetate anion without damage to the crystals. Although the effectiveness of anion-triggered reversal of gel formation is limited by the solvent and the ability of the crystalline substrate itself to interact with the anion, gelators can be designed that respond to a variety of external stimuli. The ability of LMWGs to gel a wide range of solvents allows for detailed screening of compounds. LMWGs may act as an inert matrix, slowing down crystallization and leading to larger, more uniform crystals, and inhibiting the conversion of metastable polymorphs. In some cases crystallization was found to occur in the gel but not in solution, whereas in others nucleation required higher levels of supersaturation in the gel phase. No gelator-substrate cocrystals were observed, suggesting effective phase separation between the rapidly forming gel and the slower growing substrate crystals. This important observation indicates the general applicability of these systems.
Clear differences in crystal habit have been seen in the gel phase when compared with solution, and in some cases the gel-phase crystallization results in the formation of different polymorphs when compared to the parallel solution-phase experiments. The vast body of literature on supramolecular gels provides a library of gelators that can be chosen to match the crystallization conditions of interest. The diversity of this class of gelator also allows for tuning of interactions between gel and solute. Supramolecular gels could find application as an important tool within the context of the polymorph screening methodologies that are routinely applied at several stages in the drug development pipeline, and work is in progress on new API materials in collaboration with industry. The high-quality single crystals that result from gel-phase crystallizations are of great potential use in macromolecular crystallography, where crystal quality, particularly in synchrotron work on small samples, is of paramount importance.
Methods
Gel-phase crystallizations were carried out by weighing the appropriate amount of substrate (1-5 wt%) and gelator (0.1-1 wt%) in a vial and adding a suitable solvent from a stock solution. The sealed vial was then heated until both solids were fully dissolved and the mixture was then allowed to cool to room temperature. In each case the gel was formed over a period of a few minutes, whereas crystallization took place over tens of minutes to weeks. Where possible, recovery of the crystals was achieved by adding a measured amount of acetate as the TBA salt to break down the gels, followed by filtration of the resulting solution and washing with water or diethyl ether. Polymorphs were identified from their characteristic solid-state IR spectra (PE Spectrum 100) or, where crystal size permitted, from the unit cell dimensions of a number of representative single crystals (Bruker 6000), or by comparing experimental XRPD patterns (D5000) with those calculated from the known singlecrystal coordinates. Rheology was carried out in a concentric cylinder couette on a 
